Gene · 715
Papers2,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 2,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chronic Refractory Immune Thrombocytopenia Is Associated With Variants in Immune Genes. | Clin Appl Thromb Hemost | 2021 | 34786962 | PubTator, text mining | PubMed |
| Early pregnancy regulates expression of complement components in ovine liver. | Anim Sci J | 2021 | 34786795 | PubTator, text mining | PubMed |
| Editorial: Recent Advances in In Vitro and In Vivo Multi-Omics Analyses of Extracellular Vesicles: Therapeutic Targets and Biomarkers. | Front Mol Biosci | 2021 | 34778382 | PubTator, text mining | PubMed |
| Proteomic Phenotyping of Stimulated Müller Cells Uncovers Profound Pro-Inflammatory Signaling and Antigen-Presenting Capacity. | Front Pharmacol | 2021 | 34776983 | PubTator, text mining | PubMed |
An Insight into the Role of Postmortem Immunohistochemistry in the Comprehension of the Inflammatory Pathophysiology of COVID-19 Disease and Vaccine-Related Thrombotic Adverse Events: A Narrative Review. | Int J Mol Sci | 2021 | 34769454 | PubTator, text mining | PubMed |
| Development and Characterization of a Multiplex Assay to Quantify Complement-Fixing Antibodies against Dengue Virus. | Int J Mol Sci | 2021 | 34769432 | PubTator, text mining | PubMed |
| A Structural Basis for Inhibition of the Complement Initiator Protease C1r by Lyme Disease Spirochetes. | J Immunol | 2021 | 34759015 | PubTator, text mining | PubMed |
| Candidate genes of SARS-CoV-2 gender susceptibility. | Sci Rep | 2021 | 34753980 | PubTator, text mining | PubMed |
| Extracellular vesicles released by human retinal pigment epithelium mediate increased polarised secretion of drusen proteins in response to AMD stressors. | J Extracell Vesicles | 2021 | 34750957 | PubTator, text mining | PubMed |
| Evaluation of Placentation and the Role of the Aryl Hydrocarbon Receptor Pathway in a Rat Model of Dioxin Exposure. | Environ Health Perspect | 2021 | 34747641 | PubTator, text mining | PubMed |
| Oral manifestations of Ehlers-Danlos syndromes. | Am J Med Genet C Semin Med Genet | 2021 | 34741498 | PubTator, text mining | PubMed |
| Tumor relevant protein functional interactions identified using bipartite graph analyses. | Sci Rep | 2021 | 34728699 | PubTator, text mining | PubMed |
| A novel C-type lectin activates the complement cascade in the primitive oyster Crassostrea gigas. | J Biol Chem | 2021 | 34715129 | PubTator, text mining | PubMed |
| Tipping the balance: intricate roles of the complement system in disease and therapy. | Semin Immunopathol | 2021 | 34698894 | PubTator, text mining | PubMed |
| Melanocytes in black-boned chicken have immune contribution under infectious bursal disease virus infection. | Poult Sci | 2021 | 34695633 | PubTator, text mining | PubMed |
| Role of uromodulin and complement activation in the progression of kidney disease. | Oncol Lett | 2021 | 34691256 | PubTator, text mining | PubMed |
| Shedding Light on the Possible Link between ADAMTS13 and Vaccine-Induced Thrombotic Thrombocytopenia. | Cells | 2021 | 34685765 | PubTator, text mining | PubMed |
| The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases? | J Clin Med | 2021 | 34682837 | PubTator, text mining | PubMed |
| Impact of Protein Corona on the Biological Identity of Nanomedicine: Understanding the Fate of Nanomaterials in the Biological Milieu. | Biomedicines | 2021 | 34680613 | PubTator, text mining | PubMed |
| Modulation of the Complement System by Neoplastic Disease of the Central Nervous System. | Front Immunol | 2021 | 34671342 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/715/papers?page=39